Efficacy Study of Additional Intraperitoneal Chemotherapy to Treat Ovarian Cancer

NCT00919984 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

22

Enrollment

OTHER

Sponsor class

Stopped This study stopped due to slow accrual.

Conditions

Ovarian Neoplasms

Interventions

DRUG: IP chemotherapy

Sponsor

Korea Cancer Center Hospital